Pharmacologic Response to CPB Flashcards
When CPB is employed in cardiac surgery it may profoundly affect
the way drugs are distributed and cleared by the body and how drugs interact with the body to produce their effects.”
Pharmacokinetics
What the body does to the drug
Pharmacodynamics
How a drug interacts with the body to produce its effects
First order kinetics
elimination of a drug occurs at a constant fraction of drug remaining in the body per unit of time
Zero order kinetics:
when drug administration exceeds the body’s ability to clear it, leading to drug accumulation
To prevent drug accumulation,
drug infusion rates should be adjusted according to patient response.
Changes in Pharmacokinetics due to CPB
• Hemodilution • Hypothermia • Perfusion • Acid-BaseStatus • Sequestration
Hemodilution causes
- Reductionincirculatingproteinconcentration
- ReductioninRBCconcentration
- Reduction in concentration of free drug (unless your pump prime matches exactly)
- Alterations in organ blood flow, affecting distribution and clearance
What happens if you add drugs to your prime BEFORE RAP or AFTER RAP??
changes concentration takes some away
Hypothermia fluid shifts
romintravasculartointerstitialspace • Alteredvolumeofdistribution • Increased 3rd spacing
hypothermia vasoconstriction
Changes in organ perfusion
hypothermia and enzymes
Reductionsinenzyme-mediatedbiotransformation
hypothermia and solubility of volatile anesthetics
Increased solubility
altered hepatic flow by these drugs
(Fentanyl, propofol)
lungs excluded from circulation so give these drugs
(Valium,propofol,opioids)
Acid Base Status alters
organ blood flow • pH stat = ↑ cerebral blood flow
• Alteredionizationandproteinbinding
Drugs may be taken up by various components of the CPB circuit
Coated tubing
• Oxygenators
• Hemofilters • Many factors influence the movement of drug across the
membrane • Degree of protein binding is a major determinant
Administering medications ensure that
• you have a physician’s order or standing protocol
authorizing you to administer the medication
• the patient is not allergic to the medication
• you have the correct medication, the correct concentration and the correct dosage
• Inspect the medication for expiration date, precipitates, and sterility
What is in your drug box?
Heparin • Neo-Synephrine • NaHCO3 • Lidocaine • MgSO4 • Calcium • Potassium • Mannitol
Heparin Sodium derived from
bovine lung tissue or porcine mucosa standardized for anticoagulant activity
heparin sodium potency is determined by
biological assay using a USP reference standard based on units of heparin activity per milligram
• 100 units = 1 milligram • Example: 5,000 units = 50mg
heparin sodium action
Action: stops coagulation by potentiating antithrombin III and inhibiting the action of activated Factors IX and XI
Heparin Pharmacokinetics
- Eliminated by kidneys • Half life at CPB doses is 2 or more hours
- Prolonged by hypothermia and renal blood flow alterations
Heparin Side Effects
• Activation of t-PA and platelets • Boluses decrease SVR by 10 to 20% • Anaphylaxisrarelyoccurs • HITandHITT
HLD
300 to 450 units/kg . Rarely need to exceed 35,000 to 40,000 units
Heparin distributes
primarily in plasma, so increasing dose with
increasing body weight is only relevant to a certain point
Priming solution should contain heparin at approximately the same
concentration of the patient’s blood stream
ACT is prolonged by
hypothermia and hemodilution • Target ACT controversial (300 to 480 seconds)
Most vials you will see for adult CPB will be
1000 units/mL Loading dose: 30,000 units
30,000 units x 1mL = 30 mL 1000 units
neo action
syntheticselectiveα1-adranergicagonistthat causes vasoconstriction in arterioles
neo duration
less than 5 minutes
neo other things
Titratedtoeffect • Start with a test dose
Neo-Synephrine Dosing IV bolus
• 100 micrograms/mL • 200 micrograms/mL • 400micrograms/mL
Neo-Synephrine Dosing IV infusion
10 or 15 mg in 250 mL IV fluid (40 to 60 micrograms/mL)
Sodium Bicarbonate
Asterile,nonpyrogenic,hypertonicsolutionofsodium bicarbonate (NaHCO3) in water for injection for administration by the intravenous route as an electrolyte replenisher and system alkalizer
• Also used to treat hyperkalemia
NaHCO3 Dosing
- Dose (mEq) = 0.3 x Weight (kg) x BD (mEq/L) *Or just “1 amp” (50 mEq)
- Hyperkalemia: • Adults:50mEq • Peds: 1-2 mEq/kg
Lidocaine actions
reduces cell membrane permeability for sodium and potassium which increases the stimulation thresholds in ventricles
lidocaine site of action
cellmembrane